60 Degrees Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 0.9475 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.33M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zi...